News

Persistent health disparities in the US signal need for new thinking

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e6204 (Published 13 September 2012) Cite this as: BMJ 2012;345:e6204

Re: Persistent health disparities in the US signal need for new thinking

The article by Epstein[1] reporting on the recent Institute of Medicine Workshop on health disparities [2] suggests that after more than a decade of government reports and other initiatives, there needs to be new thinking about how to deal with health disparities in the United States. But such thinking can be of little value if not informed by an understanding of how badly flawed research into health disparities has been as a result of the failure to recognize the way standard measures of differences between outcome rates tend to affected by the prevalence of an outcome.

For reasons related to the shapes of distributions of factors associated with experiencing an outcome, the rarer the outcome the greater tends to be the relative difference in experiencing it and the smaller tends to be the relative difference in avoiding it. Thus, for example, as mortality declines, relative difference in mortality tend to increase while relative differences in survival tend to decrease; as rates of appropriate healthcare increase, relative differences in receipt of appropriate care tend to decrease, while relative differences in rates of failing to receive appropriate care tend to increase. As prevalence of a health or healthcare outcome changes, absolute differences tend to change in the same direction as the smaller relative difference. And, irrespective of the shapes of the underlying distributions, when an absolute difference and a relative difference have changed in opposite directions (as will frequently be noted), the unmentioned relative difference will have changed in the opposite direction of the mentioned relative difference and in the same direction as the absolute difference.[3-6]

In 2005, the National Center for Health Statistics (NCHS) recognized the pattern by which relative differences in favorable outcomes and relative differences in adverse outcomes tend to change in opposite directions as the prevalence of an outcome changes.[7] But, rather than address the implications of such pattern with respect to the utility of either relative difference to track disparities over time without taking changes in prevalence into account, NCHS merely recommended that henceforth disparities in all health and healthcare outcomes should be measured in terms of relative differences in adverse outcomes. According to this approach, which underlies Health and Human Services’ appraisals of achievement of the health disparities reduction goals in Healthy People 2020, healthcare disparities that previously were regarded as decreasing now would be deemed to be increasing. See Table 3 of ref. 5. And where researchers relying on relative differences in favorable healthcare outcome would find dramatic decreases in disparities, NCHS would find dramatic increases in disparities. See Table 4 of ref. 5.

Meanwhile, in the National Healthcare Disparities Reports, the Agency for Healthcare Research and Quality (AHRQ) measures disparities in terms of whichever relative difference (in the favorable of the adverse outcome) is larger, without a suggestion in any of the reports of an understanding that these two measures tend to change in opposites directions.[8] The scope of the failure to understand the pattern of relative differences is perhaps best reflected in the disparities studies, particularly those addressing cancer outcomes, where observers refer to disparities in survival and disparities in mortality interchangeably, sometimes purporting to analyze one while in fact analyzing the other, and without recognizing that the two change in opposite directions as survival changes over time.[9]

Increasingly, research into healthcare disparities, often funded by AHRQ, relies on absolute differences between rates, without any recognition of the way absolute differences tend to change solely because of changes in prevalence of an outcome or that reliance on absolute differences tends to yield opposite conclusions as to changes over time from those AHRQ would reach. The failure to understand the patterns by which absolute differences between rates are affected by the prevalence of an outcome has even caused Massachusetts to include a disparities measure in its Medicaid pay-for-performance program that is more likely to increase disparities than reduce them. See pages 21-24 of ref. 6.

One of the most recent guides to disparities measurement, a joint product of Harvard Medical School and Massachusetts General Hospital,[10] is substantially superior to earlier guides in that it at least discusses the importance of reporting absolute differences and both relative differences and points out that the two relative differences can yield different conclusions as to changes over time. But, because it fails to reflect any recognition of the patterns by which the measures it discusses tend to be affected by overall prevalence, or the implications of such patterns with respect to efforts to determine whether the forces causing a disparity have increased or decreased, this guide will lead to further flawed disparities research. See pages 42-43 of ref.6

The Institute of Medicine report fails to reflect any understanding of the above measurement issues. While some of its discussion may be of value, the failure to recognize those issues materially undermines its overall utility.

References:

1. Epstein K. Persistent health disparities in the US signal for new thinking. BMJ 2012;345:e6204 doi: 10.1136/bmj.e620

2. Institute of Medicine of the National Academies. How far have we come in reducing health
disparities? Progress since 2000. www.iom.edu/Reports/2012/How-Far-Have-We-Comein-
Reducing-Health-Disparities.aspx.

3. Scanlan JP. Can we actually measure health disparities? Chance 2006:19(2):47-51. http://www.jpscanlan.com/images/Can_We_Actually_Measure_Health_Dispariti...

4. Scanlan JP. Race and mortality. Society 2000;37(2):19-35. http://www.jpscanlan.com/images/Race_and_Mortality.pdf

5. Scanlan JP. The Mismeasure of Group Differences in the Law and the Social and Medical Sciences. Applied Statistics Workshop at the Institute for Quantitative Social Science at Harvard University, Oct. 17, 2012. http://jpscanlan.com/images/Harvard_Applied_Statistic_Workshop.ppt

6. Scanlan JP. Harvard University Measurement Letter. Oct. 9, 2012. http://jpscanlan.com/images/Harvard_University_Measurement_Letter.pdf

7. Keppel K., Pamuk E., Lynch J., et al. (2005) Methodological Issues in Measuring Health Disparities. Vital Health Stat;2 (141): http://www.cdc.gov/nchs/data/series/sr_02/sr02_141.pdf

8. Scanlan JP. Measurement Problems in the National Healthcare Disparities Report, presented at American Public Health Association 135th Annual Meeting & Exposition, Washington, DC, Nov. 3-7, 2007: PowerPoint Presentation: http://www.jpscanlan.com/images/ORAL_ANNOTATED.pdf

9. Mortality and Survival Page of jpscanlan.com: http://jpscanlan.com/mortalityandsurvival2.html

10. Weinstein JS, Betancourt JR, Green AR, et al.. Commissioned Paper: Measuring Healthcare Disparities, Disparities Solution Center, Oct. 4, 2011: http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemI...

Competing interests: No competing interests

04 February 2013
James P. Scanlan
Attorney
James P. Scanlan, Attorney at Law
1529 Wisconsin Ave., NW, Washington, DC 20007 USA
Click to like:
90